Korean J Pain.  2024 Oct;37(4):285-287. 10.3344/kjp.24298.

Neutraceuticals may supplement pharmaceutical treatment of neuropathic pain

• Kim WM

• KMID: 2559690
• DOI: http://doi.org/10.3344/kjp.24298

Reference

1. Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, et al. Classification Committee of the Neuropathic Pain Special Interest Group (NeuPSIG). 2019; The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain. 160:53–9. DOI: 10.1097/j.pain.0000000000001365. PMID: 30586071. PMCID: PMC6310153.

2. Attal N, Bouhassira D. 2021; Advances in the treatment of neuropathic pain. Curr Opin Neurol. 34:631–7. DOI: 10.1097/WCO.0000000000000980. PMID: 34310363.

3. Taneja A, Della Pasqua O, Danhof M. 2017; Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm. Eur J Clin Pharmacol. 73:1219–36. DOI: 10.1007/s00228-017-2301-8. PMID: 28894907. PMCID: PMC5599481.

4. Kim M, Park SK, Kim WM, Kim E, Kim H, Park JM, et al. 2024; Updated guidelines for prescribing opioids to treat patients with chronic non-cancer pain in Korea: developed by committee on hospice and palliative care of the Korean Pain Society. Korean J Pain. 37:119–31. DOI: 10.3344/kjp.24022. PMID: 38557654. PMCID: PMC10985489.

5. Oh J, Yeo J. 2024; Trends in the prescription of opioids and gabapentinoids in patients with failed back surgery syndrome in Korea: a population-based study. Korean J Pain. 37:73–83. DOI: 10.3344/kjp.23246. PMID: 38130090. PMCID: PMC10764216.

6. Yoon SH, Kim J, Yoon S, Lee HJ. 2024; Current status of opioid prescription in South Korea using narcotics information management system. Korean J Pain. 37:41–50. DOI: 10.3344/kjp.23234. PMID: 38061773. PMCID: PMC10764218.

7. Kim EJ, Hwang EJ, Yoo YM, Kim KH. 2022; Prevention, diagnosis, and treatment of opioid use disorder under the supervision of opioid stewardship programs: it's time to act now. Korean J Pain. 35:361–82. DOI: 10.3344/kjp.2022.35.4.361. PMID: 36175336. PMCID: PMC9530691.

8. Ramadhani A, Astuti I, Widiastuti MG, Purwanti N. 2024; Methylcobalamin as a candidate for chronic peripheral neuropathic pain therapy: review of molecular pharmacology action. Korean J Pain. 37:299–309. DOI: 10.3344/kjp.24171. PMID: 39344358.

9. Rickes EL, Brink NG, Koniuszy FR, Wood TR, Folkers K. 1948; Crystalline Vitamin B12. Science. 107:396–7. DOI: 10.1126/science.107.2781.396. PMID: 17783930.

10. Zhang M, Han W, Hu S, Xu H. 2013; Methylcobalamin: a potential vitamin of pain killer. Neural Plast. 2013:424651. DOI: 10.1155/2013/424651. PMID: 24455309. PMCID: PMC3888748.

11. Huang ZF, Lin BQ, Torsha TT, Dilshad S, Yang DS, Xiao J. 2019; Effect of Mannitol plus Vitamins B in the management of patients with piriformis syndrome. J Back Musculoskelet Rehabil. 32:329–37. DOI: 10.3233/BMR-170983. PMID: 30412481.

12. Xu G, Lv ZW, Feng Y, Tang WZ, Xu GX. 2013; A single-center randomized controlled trial of local methylcobalamin injection for subacute herpetic neuralgia. Pain Med. 14:884–94. DOI: 10.1111/pme.12081. PMID: 23566267.

13. Akaike A, Tamura Y, Sato Y, Yokota T. 1993; Protective effects of a vitamin B12 analog, methylcobalamin, against glutamate cytotoxicity in cultured cortical neurons. Eur J Pharmacol. 241:1–6. DOI: 10.1016/0014-2999(93)90925-8. PMID: 7901032.

14. Buesing S, Costa M, Schilling JM, Moeller-Bertram T. 2019; Vitamin B12 as a treatment for pain. Pain Physician. 22:E45–52. DOI: 10.36076/ppj/2019.22.E45. PMID: 30700078.